FLCCC Weekly Updates
Every Wednesday evening at 7 pm Eastern Time, the Front Line COVID-19 Critical Care Alliance (FLCCC) presents a live, virtual “Weekly Update” webinar on COVID-19. During each event, FLCCC Creative Director Betsy Ashton introduces FLCCC physicians and guests, who provide the latest information about the status of the pandemic, emerging COVID-19 therapeutics, and the doses and medicines in FLCCC prevention and treatment protocols, plus takes audience questions that the doctors answer live.
- Recordings of all past Weekly Updates follow, with the most recent on top.
- To register for future webinars, please visit our ZOOM webinar registration page
In this week’s episode, Dr. Pierre Kory introduces the I-RECOVER Protocol for Long Haul COVID-19 Syndrome along with the brilliant doctors and COVID-19 experts who collaborated on the development of the protocol. Guests include Drs. Paul Marik, Tina Peers, Ram Yogendra, and Dr. Mobeen Syed.
In this week’s episode, Dr. Pierre Kory and Dr. Paul Marik introduce the I-MASS Protocol—which was created for generalized distribution during mass outbreaks and in low-resource countries.icating endemic parasitic infections in many parts of the world.
In this episode, Dr. Pierre Kory, Chief Medical Officer of the FLCCC Alliance is joined by Steve Kirsch, who has become a champion of early treatment for COVID-19 through his foundation, The COVID-19 Early Treatment Fund, at treatearly.org. Steve’s article on why the NIH and WHO treatment recommendations need fixing can be found here.
In this episode, Dr. Pierre Kory, Chief Medical Officer of the FLCCC Alliance, discusses the ways that public health organizations are manipulating scientific data on early COVID-19 therapeutics in order to sow uncertainty; and why they are doing it.
Dr. Kory discusses the humanitarian COVID-19 tragedy in India—why it is happening… and what we know about Ivermectin’s ability to stop COVID-19 in an Indian state (Uttar Pradesh) where it has been in widespread use. He also details the updates to our MATH+ and I-MASK+ protocols.
“The WHO is completely compromised,” says Dr. Kory. “They are protecting other interests.”
The scale of the markets (think vaccines and pharmaceutical companies) that would be affected by the approval of ivermectin for the prevention and treatment of COVID-19 is massive. Meanwhile, because the WHO failed to recommend ivermectin for worldwide use, hundreds of thousands of the world’s most vulnerable people are now on the way to their deaths.
Drs. Jose Morgenstern and Jose Redondo of the Dominican Republic share their new ivermectin study and tell the story of how they discovered the efficacy of ivermectin in April, 2020.
In this episode, Dr. Pierre Kory and Betsy Ashton discuss the incomprehensible decision of the World Health Organization not to recommend ivermectin for every phase of COVID-19 disease. This, in spite of the mountains of solid science and medical evidence that show ivermectin to be an efficacious, inexpensive and safe way out of this pandemic. Plus, Dr. Kory answers webinar attendees’ questions.
Dr. Pierre Kory discusses the significance of the British Ivermectin Recommendation Development (BIRD) Meeting held on February 20, 2021, via Zoom from Bath, United Kingdom. Dr. Kory also spends extra time answering listener questions.